4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-017212
President and CEO sold 20,000 shares at an average $12.65 ($253,052)
- President and CEO acquired 66,665 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2022-03-04 | Option exercise | +66,665 | $0.25 | $16,666 | 7,956,040 | D |
| Jiang Wenbin President and CEO | 2022-03-07 | Sale | −18,800 | $12.58 | $236,504 | 7,937,240 | D |
| Jiang Wenbin President and CEO | 2022-03-07 | Sale | −1,200 | $13.79 | $16,548 | 7,936,040 | D |
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2022-03-04 | Option exercise · Stock Option (Right to Buy) | −66,665 | 0 | D | ||
| Open-market sales · 20,000 sh · avg $12.65 · $253,052 | |||||||
Loading xslF345X03/doc4.xml…